Advertisement

#voxilaprevir

Vosevi Is Effective for Retreatment of Hepatitis C

Adding ribavirin led to more side effects but did not improve the likelihood of a cure.

Vosevi

AbbVie and Gilead Get European Recommendation for New Hepatitis C Combos

Maviret and Vosevi were highly effective and well tolerated in clinical trials.

Gilead Files for FDA OK of New All-Genotype Hepatitis C Treatment

The triple-drug combo would be the first once-daily, single-tablet regimen for those with all genotypes who’ve failed a previous treatment.

Excellent Results for Gilead’s Experimental Regimen for All Hep C Genotypes

Gilead has tested the addition of the investigational voxilaprevir to its already approved Epclusa (sofosbuvir/velpatasvir).

Advertisement